News

Lipoxen Receives Bio Entrepreneur of the Year Award

13 July 2006

award

Lipoxen PLC (AIM: LPX), a biopharmaceutical company specialising in the development of high value differentiated biologicals, vaccines and anti-cancer therapeutics drugs, is very pleased to announce that it has received the UK Trade & Investment Special Award 2006. The award, which was presented yesterday in a ceremony at the Foreign and Commonwealth Office in , is in recognition of Lipoxen’s product development efforts in in partnership with local business, namely the Serum Institute of India, one of the world’s leading vaccine companies.

The award received by Lipoxen is one of several presented yesterday by UK Trade & Investment in association with London First as part of the 2006 UK Biotechnology Innovation Awards. These awards are designed to recognise the achievements of the ’s growing biotechnology sector and are voted on by a panel of leading biotechnology industry figures, including Simon Best, Chairman of the UK BioIndustry Association and Sir William Castell, Chair of the Wellcome Trust.

Download Full Document